Table 1.
Unique ID | Group | Age (year) | Gender | Nephrectomy type | Creatinine | Primary tumour status | Tumour size (mm) | Fuhrmann grade | Leibovich Score 20031 | Leibovich Score 20182 | Time to metastasis (days) | Pair ID |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RCC01 | Progressor | 72 | Female | Radical | 106 | T1a | 20 | 2 | 0 | 2 | 2680 | 5 |
RCC02 | Progressor | 72 | Male | Radical | 109 | T1b | 50 | 2 | 2 | 5 | 2319 | 6 |
RCC03 | Progressor | 66 | Male | Radical | 113 | T1a | 35 | 3 | 1 | 3 | 2632 | 3 |
RCC05 | Progressor | 83 | Male | Radical | 81 | T1b | 50 | 2 | 2 | 5 | 109 | 7 |
RCC06 | Progressor | 67 | Male | Radical | 176 | T1b | 48 | 2 | 2 | 5 | 1385 | 8 |
RCC08 | Progressor | 63 | Male | Radical | 60 | T1a | 40 | 3 | 1 | 3 | 1994 | 2 |
RCC09 | Progressor | 51 | Female | Radical | 58 | T1a | 38 | 3 | 2 | 5 | 1544 | 1 |
RCC11 | Progressor | 66 | Male | Partial | 61 | T1a | 15 | 3 | 2 | 5 | 965 | 4 |
RCC04 | Nonprogressor | 63 | Male | Radical | 82 | T1b | 50 | 2 | 2 | 5 | 6 | |
RCC07 | Nonprogressor | 76 | Male | Radical | 98 | T1b | 45 | 2 | 2 | 5 | 7 | |
RCC10 | Nonprogressor | 78 | Female | Partial | 64 | T1a | 20 | 2 | 0 | 2 | 5 | |
RCC12 | Nonprogressor | 63 | Male | Radical | 80 | T1b | 45 | 2 | 2 | 5 | 8 | |
RCC13 | Nonprogressor | 34 | Male | Partial | 73 | T1a | 23 | 3 | 1 | 3 | 1 | |
RCC14 | Nonprogressor | 72 | Male | Partial | 97 | T1b | 55 | 2 | 2 | 5 | 6 | |
RCC15 | Nonprogressor | 75 | Male | Radical | 73 | T1b | 45 | 2 | 2 | 5 | 7 | |
RCC16 | Nonprogressor | 62 | Male | Radical | 82 | T1a | 30 | 3 | 1 | 3 | 3 | |
RCC17 | Nonprogressor | 54 | Male | Partial | 68 | T1a | 35 | 3 | 1 | 3 | 2 | |
RCC18 | Nonprogressor | 68 | Female | Partial | 45 | T1a | 20 | 2 | 0 | 2 | 5 | |
RCC19 | Nonprogressor | 68 | Male | Radical | 68 | T1b | 45 | 2 | 2 | 5 | 8 | |
RCC20 | Nonprogressor | 66 | Male | Radical | 67 | T1a | 30 | 3 | 1 | 3 | 2 | |
RCC21 | Nonprogressor | 57 | Male | Partial | 73 | T1a | 30 | 3 | 1 | 3 | 3 | |
RCC22 | Nonprogressor | 66 | Male | Partial | 83 | T1a | 38 | 3 | 1 | 3 | 4 | |
RCC23 | Nonprogressor | 74 | Male | Partial | 81 | T1a | 16 | 3 | 1 | 3 | 4 | |
RCC24 | Nonprogressor | 47 | Female | Partial | 48 | T1a | 40 | 3 | 1 | 3 | 1 |
One NP patient (RCC19) developed a metastasis after 10 years of follow-up.